Executive Vice President of Innovative Medicine, R&D, Johnson & Johnson
Search every verified John Reed interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. At the 2025 WMIF fireside chat, John Reed discussed Johnson & Johnson's R&D strategy, highlighting the company's work on icotrokinra, an oral pill for autoimmune diseases, and milvexian, a factor 11 inhibitor for anticoagulation. He noted that many patients eligible for biologics avoid them due to injection or safety concerns, and described milvexian as targeting a large unmet need among patients who cannot take existing anticoagulants due to bleeding risks. He also discussed the company's oncology pipeline, including a bispecific antibody targeting KLK2 for prostate cancer, which he said had advanced from phase one to phase three trials. In a 2017 interview at GapSummit, Reed, then at Roche, spoke about balancing innovation with shareholder demands in the pharmaceutical industry, emphasizing the importance of committing to long-term innovation and risk-taking. He also advised scientists on career development, stressing the value of collaboration, communication skills, and pursuing ambitious goals.
Fireside Chat: Focus on J&J Speaker John Reed, MD, PhD, Executive Vice President, Innovation Medicine, R&D, Johnson & Johnson Moderator Tim Anderson, MD, Pharmaceutical Analyst, BofA Securities
Dr John Reed, Head of Pharma Research & Early Development (pRED) at Roche, share his thoughts on GapSummit, healthcare trends and transition from science to exec role, at world's premier inter-generational leadership summit in biotechnology at Georgetown University, Washington DC, USA. Interviewer: Toryn from Global Biotech Revolution. Follow us on Twitter @GlobalBRev and Facebook: GlobalBiotechRevolution Dr Reed is Global Head of Roche Pharma Research & Early Development (pRED), responsible for directing research and early development activities from target through to Phase II, proof-of-con…
Sign in to search the full transcript archive, filter by topic, and access every quote from John Reed.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans